301 related articles for article (PubMed ID: 36247464)
1. Defective efferocytosis of vascular cells in heart disease.
Singh B; Li K; Cui K; Peng Q; Cowan DB; Wang DZ; Chen K; Chen H
Front Cardiovasc Med; 2022; 9():1031293. PubMed ID: 36247464
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis.
Yurdagul A; Doran AC; Cai B; Fredman G; Tabas IA
Front Cardiovasc Med; 2017; 4():86. PubMed ID: 29379788
[TBL] [Abstract][Full Text] [Related]
3. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
[TBL] [Abstract][Full Text] [Related]
4. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
5. Efferocytosis of vascular cells in cardiovascular disease.
Cabrera JTO; Makino A
Pharmacol Ther; 2022 Jan; 229():107919. PubMed ID: 34171333
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Efferocytosis in Cardiac Pathophysiology and Repair.
Li Y; Li Q; Fan GC
Shock; 2021 Feb; 55(2):177-188. PubMed ID: 32694395
[TBL] [Abstract][Full Text] [Related]
7. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution.
Dhawan UK; Singhal A; Subramanian M
Pharmacol Res; 2021 Aug; 170():105699. PubMed ID: 34087352
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
Thorp E; Tabas I
J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis.
Kumar D; Pandit R; Yurdagul A
Immunometabolism (Cobham); 2023 Jan; 5(1):e00017. PubMed ID: 36710920
[TBL] [Abstract][Full Text] [Related]
10. Ca
Tajbakhsh A; Kovanen PT; Rezaee M; Banach M; Sahebkar A
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766552
[TBL] [Abstract][Full Text] [Related]
11. Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis.
Tajbakhsh A; Kovanen PT; Rezaee M; Banach M; Moallem SA; Sahebkar A
Int J Biochem Cell Biol; 2020 Mar; 120():105684. PubMed ID: 31911118
[TBL] [Abstract][Full Text] [Related]
12. The walking dead: macrophage inflammation and death in atherosclerosis.
Kavurma MM; Rayner KJ; Karunakaran D
Curr Opin Lipidol; 2017 Apr; 28(2):91-98. PubMed ID: 28134664
[TBL] [Abstract][Full Text] [Related]
13. The Role of Efferocytosis in Atherosclerosis.
Kojima Y; Weissman IL; Leeper NJ
Circulation; 2017 Jan; 135(5):476-489. PubMed ID: 28137963
[TBL] [Abstract][Full Text] [Related]
14. The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis.
Wang Z; Su J; Gong F; Xue L; Su Z
J Cardiovasc Pharmacol; 2022 Sep; 80(3):407-416. PubMed ID: 35853202
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease.
Thorp EB
Apoptosis; 2010 Sep; 15(9):1124-36. PubMed ID: 20552278
[TBL] [Abstract][Full Text] [Related]
16. Contrasting Inflammation Resolution during Atherosclerosis and Post Myocardial Infarction at the Level of Monocyte/Macrophage Phagocytic Clearance.
Thorp EB
Front Immunol; 2012; 3():39. PubMed ID: 22566922
[TBL] [Abstract][Full Text] [Related]
17. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
Yurdagul A
Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
[TBL] [Abstract][Full Text] [Related]
18. Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque.
Cao Y; Yao J; Gao W; Cao Z; Diabakte K; Wang L; Sun X; Tian Y
Int Heart J; 2022 Jan; 63(1):131-140. PubMed ID: 35034916
[TBL] [Abstract][Full Text] [Related]
19. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
20. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation.
Schilperoort M; Ngai D; Sukka SR; Avrampou K; Shi H; Tabas I
Immunol Rev; 2023 Oct; 319(1):65-80. PubMed ID: 37158427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
